Some key factors of the report
Net services revenues for the second quarter of 2010 was $151.9 million, an increase of $26.2 million, or 21% over the second quarter of 2009.
Operating margin for the second quarter of 2010 was $33.9 million, an increase of $11.2 million, or 49% over the second quarter of 2009.
Income from operations for the second quarter of 2010 was $7.4 million, an increase of $4.5 million, or 155% over the second quarter of 2009.
Net income attributable to common shareholders for the second quarter of 2010 was $3.9 million, an increase of $1.3 million, or 48% over the second quarter of 2009.
Non-GAAP adjusted EBITDA was $12.3 million for the second quarter of 2010, an increase of $6.3 million, or 105% over the second quarter of 2009.
Non-GAAP adjusted net income per diluted common share was $0.07 for the quarter ended June 30, 2010.
Diluted earnings per common share was $0.04 for the quarter ended June 30, 2010.
The Company’s projected contracted annual revenue run rate at June 30, 2010 was $614 million to $626 million compared to $483 million to $493 million at June 30, 2009. The midpoint of the range at June 30, 2010 increased by $132 million, or 27%, from the midpoint of the range at June 30, 2009.
Mary Tolan, Accretive Health’s Co-Founder and Chief Executive Officer said, “We are very pleased with our results for the second quarter, our continuing top-line growth, our margin expansion and our increasing profitability. These results are driven by the increasing level of value we deliver to our customers through both net revenue yield improvements and operating efficiencies.
Management estimates that the company’s projected contracted annual run rate of revenue at the end of 2010 will exceed $710 million, an increase of at least 38% from the $510 million to $519 million (midpoint of $514 million) projected contracted annual revenue run rate at the end of 2009.
Recent RCM News
- R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- R1 RCM Forms Special Committee to Evaluate Strategic Alternatives • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:11:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 02:08:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:01:25 PM
- R1 RCM Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:16:06 AM
- R1 RCM to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/16/2024 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:23:10 PM
- R1 Wins Multiple Best in KLAS Awards for Third Straight Year • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:13:53 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 09:37:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:31:57 PM
- R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services Business • GlobeNewswire Inc. • 01/17/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:02:33 PM
- R1 RCM Announces Preliminary Fourth Quarter Results • GlobeNewswire Inc. • 01/08/2024 12:00:00 PM
- R1 RCM to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/21/2023 10:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:07:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:04:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 11:01:29 AM
- R1 RCM to Acquire Acclara • GlobeNewswire Inc. • 12/06/2023 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/04/2023 01:00:55 PM
- R1 Completes Restatement of Previously Issued Financial Statements • GlobeNewswire Inc. • 12/04/2023 01:00:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/04/2023 12:50:26 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/04/2023 12:40:50 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM